Literature DB >> 27567407

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen, Željko Reiner, Gabriele Riccardi, Marja-Riita Taskinen, Lale Tokgozoglu, W M Monique Verschuren, Charalambos Vlachopoulos, David A Wood, Jose Luis Zamorano, Marie-Therese Cooney.   

Abstract

Keywords:  apolipoprotein B; cholesterol; dyslipidaemias; high-density lipoproteins; lipoprotein remnants; low-density lipoproteins; total cardiovascular risk; treatment, adherence; treatment, drugs; treatment, lifestyle; triglycerides

Mesh：

Year:  2016        PMID： 27567407     DOI： 10.1093/eurheartj/ehw272

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  575 in total

1.  Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.

Authors:  Elina Nikkola; Arthur Ko; Marcus Alvarez; Rita M Cantor; Kristina Garske; Elliot Kim; Stephanie Gee; Alejandra Rodriguez; Reinhard Muxel; Niina Matikainen; Sanni Söderlund; Mahdi M Motazacker; Jan Borén; Claudia Lamina; Florian Kronenberg; Wolfgang J Schneider; Aarno Palotie; Markku Laakso; Marja-Riitta Taskinen; Päivi Pajukanta
Journal:  Atherosclerosis       Date:  2017-07-22       Impact factor: 5.162

2.  Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease.

Authors:  Leonardo De Luca; Marcello Arca; Pier L Temporelli; Furio Colivicchi; Lucio Gonzini; Donata Lucci; Biagio Bosco; Mariella Callerame; Giulio V Lettica; Andrea Di Lenarda; Michele M Gulizia
Journal:  Clin Cardiol       Date:  2018-08-20       Impact factor: 2.882

3.  Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.

Authors:  Najmeh Ahangari; Mohammad Doosti; Majid Ghayour Mobarhan; Amirhossein Sahebkar; Gordon A Ferns; Alireza Pasdar
Journal:  Ann Med       Date:  2020-08-24       Impact factor: 4.709

4.  Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort.

Authors:  Eric J Brandt; Arya Mani; Erica S Spatz; Nihar R Desai; Khurram Nasir
Journal:  J Clin Lipidol       Date:  2020-07-03       Impact factor: 4.766

Review 5.  Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.

Authors:  Duygu Kocyigit; Alexandra Scanameo; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

6.  Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.

Authors:  Kamlesh Khunti; Mark D Danese; Lucie Kutikova; David Catterick; Francisco Sorio-Vilela; Michelle Gleeson; Sreenivasa Rao Kondapally Seshasai; Jack Brownrigg; Kausik K Ray
Journal:  JAMA Netw Open       Date:  2018-12-07

Review 7.  Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group.

Authors:  Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

Review 8.  Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

Authors:  Ian M Graham; Alberico L Catapano
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 9.  Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?

Authors:  Evangelos C Rizos; Moses S Elisaf
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 10.  Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.